Jennifer German focuses her practice on regulatory issues that affect FDA-regulated industries. Prior to joining the firm, Jennifer served as a Regulatory Policy Analyst for Food and Drug Administration (FDA) Center for Tobacco Products (CTP) and Regulatory Counsel for Center for Drug Evaluation and Research (CDER). In these roles Jennifer analyzed and executed highly complex Freedom of Information Act (FOIA) requests. This experience gives Jennifer unique insight into the challenges and risks faced by clients in FDA-regulated industries.
Outside of work, Jennifer enjoys spending time playing with her dog, writing historical fiction and attending Pilates classes.
Professional & Civic Engagement
- Maryland State Bar Association
- American Bar Association
- Food & Drug Law Institute
- Regulatory Affairs Professional Society
- American Society of Access Professionals
- Food and Drug Administration Alumni Association
- Community Inclusive Mediator
Thought Leadership
Publications
- "Navigating New Hemp Laws: A Major Shift for the Cannabis Industry," The Journal of Federal Agency Action, July/August 2026
- "From Farm to Fork: Understanding FDA’s Food Traceability," Law Meets Science, May 15, 2026
- "FDA’s 2026 General Wellness Policy and What It Means for Manufacturers of Wearable Devices," Law Meets Science, April 9, 2026
- "Navigating New Hemp Laws: A Major Shift for the Cannabis Industry," Law Meets Science, February 12, 2026